姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Lin,Yan-Sheng | Chairman | 74.90% | United Orthopedic Corporation |
Liao,Jian-Zhong | Director | 74.90% | United Orthopedic Corporation |
Lin,Yu-Wei | Director | 0.00% | |
Yu,Zai-Jiu | Director | 0.00% | |
Huang,Shi-Han | Independent Director | 0.00% | |
Li,Ming-Xuan | Independent Director | 0.00% | |
Cai,Sheng-Wen | Independent Director | 0.00% |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Operating income | 197,368 | 391,261 | 330,157 |
Operating cost | 49,614 | 99,019 | 90,000 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 147,754 | 292,242 | 240,157 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 147,754 | 292,242 | 240,157 |
Operating expenses | 140,483 | 282,845 | 232,427 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 7,271 | 9,397 | 7,730 |
Non-operating income and expenses | 1,816 | 2,262 | 2,279 |
Net profit (loss) before tax | 9,087 | 11,659 | 10,009 |
Income tax expense (benefits) | 1,751 | 2,450 | 2,001 |
Net profit (loss) of ongoing business for the current period | 7,336 | 9,209 | 8,008 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 7,336 | 9,209 | 8,008 |
Other comprehensive profit (loss), net | 300 | 1,184 | 99 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 7,636 | 10,393 | 8,107 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | 0 | 0 |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2024 | 2023 | 2022 |
---|---|---|---|
Current asset | 356,570 | 336,182 | 329,069 |
Non-current asset | 173,936 | 178,427 | 181,939 |
Total asset | 530,506 | 514,609 | 511,008 |
Current liability | 183,047 | 192,183 | 177,047 |
Non-current liability | 79,296 | 48,428 | 56,885 |
Total liability | 262,343 | 240,611 | 233,932 |
share capital | 134,710 | 134,710 | 134,710 |
Equity - secruity token | - | - | - |
capital reserve | 35,470 | 35,470 | 35,470 |
retained earning | 98,261 | 104,396 | 108,658 |
Other equity | -278 | -578 | -1,762 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 268,163 | 273,998 | 277,076 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 19 | 20 | 20 |